Evidence map›Paper›PMID 42656955›Full record

ArticleCureus2026

Primary Cutaneous Apocrine Carcinoma of the Scalp Arising in Syringocystadenoma Papilliferum: Report of a Rare Case.

Mayar Ballaji, Ahmad Alhazmi, Sameer Albouq

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mayar BallajiGeneral Surgery, King Fahad Hospital Madinah, Madinah, SAU.
Ahmad AlhazmiGeneral Surgery, King Fahad Hospital Madinah, Madinah, SAU.
Sameer AlbouqGeneral Surgery, King Fahad Hospital Madinah, Madinah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cutaneous apocrine carcinoma (PCAC) is an exceptionally rare malignant adnexal neoplasm arising from apocrine sweat glands. Scalp involvement is particularly uncommon, especially when occurring in association with syringocystadenoma papilliferum (SCAP), making diagnosis and management challenging. We report the case of a 56-year-old woman with a congenital left occipital scalp lesion that remained stable for decades before demonstrating progressive enlargement over the preceding two years. Clinical examination revealed a solitary exophytic scalp mass without palpable cervical lymphadenopathy. Contrast-enhanced computed tomography (CT) demonstrated a superficial scalp lesion without calvarial or intracranial invasion. Histopathological examination following wide local excision established the diagnosis of primary cutaneous apocrine carcinoma arising in a background of SCAP with an incidental superficial basal cell carcinoma. Although immunohistochemistry was not performed, comprehensive clinicoradiological evaluation, including CT of the neck, chest, abdomen, and pelvis, mammography, breast ultrasonography with core biopsy confirming fibroadenoma, and whole-body bone scintigraphy, excluded an extracutaneous primary malignancy and metastatic disease. Surgical margins were negative, and the patient remains disease-free on follow-up. This case highlights the importance of considering malignant transformation in longstanding scalp lesions demonstrating recent clinical change, the role of comprehensive staging investigations in excluding metastatic disease, and the value of complete surgical excision with long-term surveillance in managing this rare malignancy.

Indexed as

apocrine mixed tumorprimary apocrinescalp tumorsebaceous carcinomasebaceous cysts

Identifiers

PMID42656955
PMCPMC13507918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.